A Translational Regulatory Mechanism Mediated by Hypusinated Eukaryotic Initiation Factor 5A Facilitates β-Cell Identity and Function
Diabetes · 2024
DOI: 10.2337/db23-0148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Craig T Connors und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Indiana University Indianapolis, Indianapolis, IN. Hauptthemen laut MEDLINE: Peptide Initiation Factors, Insulin-Secreting Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
As professional secretory cells, β-cells require adaptable mRNA translation to facilitate a rapid synthesis of proteins, including insulin, in response to changing metabolic cues. Specialized mRNA translation programs are essential drivers of cellular development and differentiation. However, in the pancreatic β-cell, the majority of factors identified to promote growth and development function primarily at the level of transcription. Therefore, despite its importance, the regulatory role of mRNA translation in the formation and maintenance of functional β-cells is not well defined. In this study, we have identified a translational regulatory mechanism mediated by the specialized mRNA translation factor eukaryotic initiation factor 5A (eIF5A), which facilitates the maintenance of β-cell identity and function. The mRNA translation function of eIF5A is only active when it is posttranslationally modified (“hypusinated”) by the enzyme deoxyhypusine synthase (DHPS). We have discovered that the absence of β-cell DHPS in mice reduces the synthesis of proteins critical to β-cell identity and function at the stage of β-cell maturation, leading to a rapid and reproducible onset of diabetes. Therefore, our work has revealed a gatekeeper of specialized mRNA translation that permits the β-cell, a metabolically responsive secretory cell, to maintain the integrity of protein synthesis necessary during times of induced or increased demand. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Indiana University Indianapolis, Indianapolis, IN.
- Indiana Biosciences Research Institute, Indianapolis, IN.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN.
- Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
ORCID-Profile: Teresa L Mastracci
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Cancer Institute
- Juvenile Diabetes Research Foundation United States of America
Zitieren
APA
Connors, C. T., Villaca, C. B. P., Anderson-Baucum, E. K., Rosario, S. R., Rutan, C. D., Childress, P. J., Padgett, L. R., Robertson, M. A., & Mastracci, T. L. (2024). A Translational Regulatory Mechanism Mediated by Hypusinated Eukaryotic Initiation Factor 5A Facilitates β-Cell Identity and Function. Diabetes. https://doi.org/10.2337/db23-0148
Vancouver
Connors CT, Villaca CBP, Anderson-Baucum EK, Rosario SR, Rutan CD, Childress PJ, et al. A Translational Regulatory Mechanism Mediated by Hypusinated Eukaryotic Initiation Factor 5A Facilitates β-Cell Identity and Function. Diabetes. 2024. doi:10.2337/db23-0148
BibTeX
@article{Connors2024,
author = {Connors, Craig T and Villaca, Catharina B P and Anderson-Baucum, Emily K and Rosario, Spencer R and Rutan, Caleb D and Childress, Paul J and Padgett, Leah R and Robertson, Morgan A and Mastracci, Teresa L},
title = {A Translational Regulatory Mechanism Mediated by Hypusinated Eukaryotic Initiation Factor 5A Facilitates β-Cell Identity and Function},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0148}
}
EUVIMED